Mount Sinai
HPV Tumor DNA Liquid Biopsy Test Shows Promise for Oropharyngeal Cancer Diagnosis, Surveillance
Researchers studied the accuracy of a commercial HPV tumor DNA blood test in almost 400 patients with HPV-related oropharyngeal squamous cell carcinoma.
Linus Biotechnology Raises $16M in Series A Funding
The Mount Sinai spinout will use the funds to advance its StrandDx platform, correlating environmental exposures to biological responses.
Gene Signature Reflects Host Response to COVID-19 Infections With Low Cross-Reactivity
The researchers established a framework to generate robust host infection response signatures with the aim of improving diagnostic sensitivity.
Researchers have used qPCR to measure the transcripts from monocytes that are activated by T cells to help understand a patient's immune status.
Blood-Based PD-L1 Tracking Could Offer Improved Response Prediction for Lung Cancer Immunotherapy
Premium
While the results are from a small study, investigators are working to validate them in larger groups, hoping their method can prove itself for clinical use.